These investigators evaluated therapeutic responses using disease-activity scores and analysis of levels of CRP and SAA. Analysis of tumour size in relationship to clearance rates showed some decrease in clearance rates when the tumour size was > 7. If coadministration cannot be avoided, use extreme caution and monitor ECG; initiate droperidol at a low dose and increase the dose as needed to achieve the desired effect http://www.pharmaciesansordonnance.org/. The dosage and duration of treatment for all factor IX products depend on the severity of the factor IX deficiency, the location and extent of bleeding and the patient’s clinical condition, age and recovery of factor IX.